Previous studies have reported that the PERK-eIF2α-CHOP signaling pathway is involved in the progression of nonalcoholic fatty liver disease, as well as in liver cell apoptosis and autophagy [25]. Here, DDIT3 is linked to metabolic dysfunction-associated steatotic liver disease.